Mosaic ImmunoEngineering, Inc.
CPMV
$0.65
-$0.1057-13.99%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -40.65% | -35.30% | -7.09% | -28.52% | -22.34% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -45.50% | -40.24% | -22.18% | -41.54% | -44.61% |
| Operating Income | 45.50% | 40.24% | 22.18% | 41.54% | 44.61% |
| Income Before Tax | 49.05% | 43.97% | -1,598.47% | 27.26% | 44.65% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 48.24% | 43.97% | -1,598.47% | 27.69% | 44.65% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 48.24% | 43.97% | -1,598.47% | 27.69% | 44.65% |
| EBIT | 45.50% | 40.24% | 22.18% | 41.54% | 44.61% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 48.28% | 44.03% | -1,603.70% | 27.59% | 44.72% |
| Normalized Basic EPS | 48.82% | 43.51% | 11.81% | 38.31% | 43.05% |
| EPS Diluted | 48.28% | 40.00% | -1,865.22% | 27.59% | 45.45% |
| Normalized Diluted EPS | 48.82% | 43.51% | -4.53% | 38.31% | 43.05% |
| Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 0.00% | 0.00% | -15.55% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |